Johan Wedell-Wedellsborg, Director at Y-mAbs Therapeutics, Inc. (YMAB), bought 6,455 shares at $6.85 ($44K) on 2023-12-11, disclosed to the SEC on 2023-12-12.
Open-market purchase of $44k YMAB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| YMAB | BUY | 2023-11-29 | $1.0M | — | Filing → |
| YMAB | BUY | 2023-05-17 | $982K | — | Filing → |
| YMAB | SELL | 2021-06-11 | $812K | — | Filing → |